Previous Close | 2.8600 |
Open | 3.0700 |
Bid | 2.8700 x 1000 |
Ask | 2.9500 x 1300 |
Day's Range | 2.8200 - 3.0700 |
52 Week Range | 2.6900 - 17.4000 |
Volume | |
Avg. Volume | 64,647 |
Market Cap | 404.013M |
Beta (5Y Monthly) | 0.32 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Shares of CASI Pharmaceuticals Inc. are actually falling in premarket trading Thursday, as a 1-for-10 reverse stock split took effect. While some quote services may still be showing a big gain for the Maryland-based biopharmaceutical company's stock, closed Wednesday at a pre-split price of 40.63 cents, meaning a 1-for-10 reverse split would adjust the price to $4.063. The stock is currently trading 15.6% below that split-adjusted price. On a pre-split basis, the stock has closed below $1 since
Viewing insider transactions for CASI Pharmaceuticals, Inc.'s ( NASDAQ:CASI ) over the last year, we see that insiders...
CASI Pharmaceuticals, Inc. (CASI) delivered earnings and revenue surprises of 40% and 0.96%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?